Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

25/09/2024

Sep 25, 2024 7:39 pm

Sep 25, 2024 7:33 pm

Sep 25, 2024 6:29 pm

Sep 25, 2024 6:19 pm

Sep 25, 2024 5:58 pm

Sep 25, 2024 5:52 pm

Sep 25, 2024 5:45 pm

Sep 25, 2024 4:31 pm

Sep 25, 2024 4:28 pm

Sep 25, 2024 4:26 pm

…

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

25/09/2024

Christy Brown: Matt Brown has accepted a role with Medtronic Cardiac and Vascular

Lucjan Wyrwicz: I had privilege to take part in PhD thesis presentation of Cieszymierz Gawiński

Tanja Obradovic: Ligufalimab plus ivonescimab combined with chemo in the first-line CRC patients

Mukhtasar Alkali: Privileged to present my work on HPV Self-Sample Collection at WCC2024

Amil Družić: I’m now part of the YCP group at the European Cancer Organisation

Francisco Esteva: Impact of COVID-19 on healthcare services

Immune checkpoint inhibitor-induced diarrhea and colitis – MASCC

Elisa Agostinetto: Datopotamab-Deruxtecan in HR+/HER2-low or negative metastatic breast cancer

Raffaele Colombo: TROPION-Breast01 results did not achieve statistical significance

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5

Headlines

25/09/2024

Christy Brown: Matt Brown has accepted a role with Medtronic Cardiac and Vascular

Lucjan Wyrwicz: I had privilege to take part in PhD thesis presentation of Cieszymierz Gawiński

Tanja Obradovic: Ligufalimab plus ivonescimab combined with chemo in the first-line CRC patients

Mukhtasar Alkali: Privileged to present my work on HPV Self-Sample Collection at WCC2024

Amil Družić: I’m now part of the YCP group at the European Cancer Organisation

Francisco Esteva: Impact of COVID-19 on healthcare services

Immune checkpoint inhibitor-induced diarrhea and colitis – MASCC

Elisa Agostinetto: Datopotamab-Deruxtecan in HR+/HER2-low or negative metastatic breast cancer

Raffaele Colombo: TROPION-Breast01 results did not achieve statistical significance

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap